BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15848)

  • 1. Induction of tolerance and withdrawal in rats receiving morphine in the spinal subarachnoid space.
    Yaksh TL; Kohl RL; Rudy TA
    Eur J Pharmacol; 1977 Apr; 42(3):275-84. PubMed ID: 15848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of "cross-tolerance" between systemic and intrathecal morphine in rats.
    Tyler CB; Advokat C
    Physiol Behav; 1986; 37(1):27-32. PubMed ID: 3755535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antinociceptive potentiation and attenuation of tolerance by intrathecal electric stimulation in rats.
    Lin CR; Yang LC; You HL; Lee CT; Tai MH; Tan PH; Lin MW; Cheng JT
    Anesth Analg; 2003 Jun; 96(6):1711-1716. PubMed ID: 12761002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of transient naloxone antagonism on tolerance development in rats receiving continuous spinal morphine infusion.
    Ibuki T; Dunbar SA; Yaksh TL
    Pain; 1997 Apr; 70(2-3):125-32. PubMed ID: 9150285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periodic abstinence enhances nociception without significantly altering the antinociceptive efficacy of spinal morphine in the rat.
    Dunbar SA; Karamian IG
    Neurosci Lett; 2003 Jul; 344(3):145-8. PubMed ID: 12812826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive potentiation and attenuation of tolerance by intrathecal β-arrestin 2 small interfering RNA in rats.
    Yang CH; Huang HW; Chen KH; Chen YS; Sheen-Chen SM; Lin CR
    Br J Anaesth; 2011 Nov; 107(5):774-81. PubMed ID: 21926413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal antagonism of tolerance and dependence induced by systemically administered morphine.
    Delander GE; Takemori AE
    Eur J Pharmacol; 1983 Oct; 94(1-2):35-42. PubMed ID: 6686142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent spinal infusion of MK801 blocks spinal tolerance and dependence induced by chronic intrathecal morphine in the rat.
    Dunbar S; Yaksh TL
    Anesthesiology; 1996 May; 84(5):1177-88. PubMed ID: 8624012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat.
    Dunbar SA; Karamian I; Zhang J
    Eur J Pain; 2007 Jan; 11(1):1-6. PubMed ID: 16448827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition by naloxone of tolerance and dependence in mice treated acutely and chronically with morphine.
    Yano I; Takemori AE
    Res Commun Chem Pathol Pharmacol; 1977 Apr; 16(4):721-34. PubMed ID: 16322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of tolerance to chronic intrathecal morphine infusion in the rat.
    Advokat C; Burton P; Tyler CB
    Physiol Behav; 1987; 39(2):161-8. PubMed ID: 3575449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinociceptive effects of intrathecally administered human beta-endorphin in the rat and cat.
    Yaksh TL; Henry JL
    Can J Physiol Pharmacol; 1978 Oct; 56(5):754-9. PubMed ID: 581358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yohimbine co-treatment during chronic morphine administration attenuates naloxone-precipitated withdrawal without diminishing tail-flick analgesia in rats.
    Taylor JR; Lewis VO; Elsworth JD; Pivirotto P; Roth RH; Redmond DE
    Psychopharmacology (Berl); 1991; 103(3):407-14. PubMed ID: 2057541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregabalin role in inhibition of morphine analgesic tolerance and physical dependency in rats.
    Hasanein P; Shakeri S
    Eur J Pharmacol; 2014 Nov; 742():113-7. PubMed ID: 25220244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the pharmacology and pathology of intrathecally administered 4-anilinopiperidine analogues and morphine in the rat and cat.
    Yaksh TL; Noueihed RY; Durant PA
    Anesthesiology; 1986 Jan; 64(1):54-66. PubMed ID: 2867722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of precipitated withdrawal from spinal morphine: changes in [Met5]enkephalin levels.
    Cridland RA; Sutak M; Jhamandas K
    Eur J Pharmacol; 1991 Oct; 203(1):93-103. PubMed ID: 1797559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic morphine administration: plasma levels and withdrawal syndrome in rats.
    Cerletti C; Keinath SH; Reidenbery MM; Alder MW
    Pharmacol Biochem Behav; 1976 Mar; 4(3):323-7. PubMed ID: 945580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
    Cavun S; Göktalay G; Millington WR
    J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultra-low dose naloxone upregulates interleukin-10 expression and suppresses neuroinflammation in morphine-tolerant rat spinal cords.
    Lin SL; Tsai RY; Tai YH; Cherng CH; Wu CT; Yeh CC; Wong CS
    Behav Brain Res; 2010 Feb; 207(1):30-6. PubMed ID: 19799935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats.
    Powell KJ; Abul-Husn NS; Jhamandas A; Olmstead MC; Beninger RJ; Jhamandas K
    J Pharmacol Exp Ther; 2002 Feb; 300(2):588-96. PubMed ID: 11805221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.